Transgenerational Metabolic-Immune Biomarkers of Neurological and Neurodevelopmental Disorders
NCT04322734
This study is recruiting at 2 US sites in 2 states, according to its ClinicalTrials.gov record last updated .
Summary
The study involves up to 5 visits for a fasting blood draw, behavioral assessments, and/or questionnaires. Other samples may be collected when appropriate. This study is currently recruiting. There is no cost for visits or study-related exams.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Autism Spectrum Disorder
- Mitochondrial Pathology
- Epilepsy
- Brain Tumor
- Psychiatric Disorder
- Mitochondrial Diseases
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- Up to 18 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Southwest Autism Research & Resource Center
- Last updated on ClinicalTrials.gov
- April 23, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Arizona · 1
- Southwestern Research and Resource Center · Phoenix, AZ
New York · 1
- State University of New York, Downstate · Brooklyn, NY
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.